Insmed | INSM - Le Coût Des Ventes

Prix De L'Action
134.66
Variation Quotidienne
-1.67 -1.23%
Mensuellement
-17.10%
Annuel
86.25%
Q2 Prévisions
132.28




Le Coût Des Ventes Changement Date
BioMarin Pharmaceutical USD 161.56M 16.62M 2025-12
Cytokinetics USD 99.23M 13.32M 2025-09
Gilead Sciences USD 1.62B 50M 2025-12
Heron Therapeutics USD 11.12M 795K 2025-12
Insmed USD 46.16M 15.25M 2025-12
Novartis USD 3.54B 7M 2025-12
Regeneron Pharmaceuticals USD 669.4M 84.8M 2026-03
Sarepta Therapeutics USD 399.38M 247.93M 2025-12
Ultragenyx Pharmaceutical USD 29M 1.01M 2025-12
Vertex Pharmaceuticals USD 466M 51.2M 2025-12